V937 treatment led to higher level of high mobility group box 1 (HMGB1) in the urine samples and cytosolic localization of the HMGB1 in the tumor tissues than the paired untreated NMIBC patient samples, suggesting V937-mediated induction of immunogenic cell death. The gene discussed is HMGB1; the disease is neoplasm.